-
Je něco špatně v tomto záznamu ?
Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging
M. Gloor, M. Andelova, L. Gaetano, A. Papadopoulou, F. Burguet Villena, T. Sprenger, EW. Radue, L. Kappos, O. Bieri, M. Garcia
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
Swiss Multiple Sclerosis Society
Swiss Multiple Sclerosis Society
NLK
ProQuest Central
od 2024-01-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost)
od 2008-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 2024-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2024-01-01 do Před 1 rokem
- MeSH
- anizotropie MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- mozek diagnostické zobrazování patologie MeSH
- roztroušená skleróza * diagnostické zobrazování patologie MeSH
- zobrazování difuzních tenzorů * metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: The potential of magnetization transfer imaging (MTI) and diffusion tensor imaging (DTI) for the detection and evolution of new multiple sclerosis (MS) lesions was analyzed. METHODS: Nineteen patients with MS obtained conventional MRI, MTI, and DTI examinations bimonthly for 12 months and again after 24 months at 1.5 T MRI. MTI was acquired with balanced steady-state free precession (bSSFP) in 10 min (1.3 mm3 isotropic resolution) yielding both magnetization transfer ratio (MTR) and quantitative magnetization transfer (qMT) parameters (pool size ratio (F), exchange rate (kf), and relaxation times (T1/T2)). DTI provided fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). RESULTS: At the time of their appearance on MRI, the 21 newly detected MS lesions showed significantly reduced MTR/F/kf and prolonged T1/T2 parameters, as well as significantly reduced FA and increased AD/MD/RD. Significant differences were already observed for MTR 4 months and for qMT parameters 2 months prior to lesions' detection on MRI. DTI did not show any significant pre-lesional differences. Slightly reversed trends were observed for most lesions up to 8 months after their detection for qMT and less pronounced for MTR and three diffusion parameters, while appearing unchanged on MRI. CONCLUSIONS: MTI provides more information than DTI in MS lesions and detects tissue changes 2 to 4 months prior to their appearance on MRI. After lesions' detection, qMT parameter changes promise to be more sensitive than MTR for the lesions' evolutional assessment. Overall, bSSFP-based MTI adumbrates to be more sensitive than MRI and DTI for the early detection and follow-up assessment of MS lesions. CLINICAL RELEVANCE STATEMENT: When additionally acquired in routine MRI, fast bSSFP-based MTI can complement the MRI/DTI longitudinal lesion assessment by detecting MS lesions 2-4 months earlier than with MRI, which could implicate earlier clinical decisions and better follow-up/treatment assessment in MS patients. KEY POINTS: • Magnetization transfer imaging provides more information than DTI in multiple sclerosis lesions and can detect tissue changes 2 to 4 months prior to their appearance on MRI. • After lesions' detection, quantitative magnetization transfer changes are more pronounced than magnetization transfer ratio changes and therefore promise to be more sensitive for the lesions' evolutional assessment. • Balanced steady-state free precession-based magnetization transfer imaging is more sensitive than MRI and DTI for the early detection and follow-up assessment of multiple sclerosis lesions.
Department of Biomedical Engineering University of Basel Allschwil Switzerland
Department of Clinical Research Faculty of Medicine University Hospital Basel Basel Switzerland
Department of Neurology University Hospital Basel Basel Switzerland
Division of Neuroradiology Department of Radiology University Hospital Basel Basel Switzerland
Division of Radiological Physics Department of Radiology University Hospital Basel Basel Switzerland
Medical Image Analysis Center AG Basel Switzerland
Novartis Institutes for BioMedical Research Basel Basel Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007006
- 003
- CZ-PrNML
- 005
- 20240423155642.0
- 007
- ta
- 008
- 240412s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00330-023-10173-6 $2 doi
- 035 __
- $a (PubMed)37658894
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Gloor, Monika $u Division of Radiological Physics, Department of Radiology, University Hospital Basel, Basel, Switzerland
- 245 10
- $a Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging / $c M. Gloor, M. Andelova, L. Gaetano, A. Papadopoulou, F. Burguet Villena, T. Sprenger, EW. Radue, L. Kappos, O. Bieri, M. Garcia
- 520 9_
- $a OBJECTIVE: The potential of magnetization transfer imaging (MTI) and diffusion tensor imaging (DTI) for the detection and evolution of new multiple sclerosis (MS) lesions was analyzed. METHODS: Nineteen patients with MS obtained conventional MRI, MTI, and DTI examinations bimonthly for 12 months and again after 24 months at 1.5 T MRI. MTI was acquired with balanced steady-state free precession (bSSFP) in 10 min (1.3 mm3 isotropic resolution) yielding both magnetization transfer ratio (MTR) and quantitative magnetization transfer (qMT) parameters (pool size ratio (F), exchange rate (kf), and relaxation times (T1/T2)). DTI provided fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). RESULTS: At the time of their appearance on MRI, the 21 newly detected MS lesions showed significantly reduced MTR/F/kf and prolonged T1/T2 parameters, as well as significantly reduced FA and increased AD/MD/RD. Significant differences were already observed for MTR 4 months and for qMT parameters 2 months prior to lesions' detection on MRI. DTI did not show any significant pre-lesional differences. Slightly reversed trends were observed for most lesions up to 8 months after their detection for qMT and less pronounced for MTR and three diffusion parameters, while appearing unchanged on MRI. CONCLUSIONS: MTI provides more information than DTI in MS lesions and detects tissue changes 2 to 4 months prior to their appearance on MRI. After lesions' detection, qMT parameter changes promise to be more sensitive than MTR for the lesions' evolutional assessment. Overall, bSSFP-based MTI adumbrates to be more sensitive than MRI and DTI for the early detection and follow-up assessment of MS lesions. CLINICAL RELEVANCE STATEMENT: When additionally acquired in routine MRI, fast bSSFP-based MTI can complement the MRI/DTI longitudinal lesion assessment by detecting MS lesions 2-4 months earlier than with MRI, which could implicate earlier clinical decisions and better follow-up/treatment assessment in MS patients. KEY POINTS: • Magnetization transfer imaging provides more information than DTI in multiple sclerosis lesions and can detect tissue changes 2 to 4 months prior to their appearance on MRI. • After lesions' detection, quantitative magnetization transfer changes are more pronounced than magnetization transfer ratio changes and therefore promise to be more sensitive for the lesions' evolutional assessment. • Balanced steady-state free precession-based magnetization transfer imaging is more sensitive than MRI and DTI for the early detection and follow-up assessment of multiple sclerosis lesions.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a zobrazování difuzních tenzorů $x metody $7 D056324
- 650 12
- $a roztroušená skleróza $x diagnostické zobrazování $x patologie $7 D009103
- 650 _2
- $a mozek $x diagnostické zobrazování $x patologie $7 D001921
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a anizotropie $7 D016880
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Andelova, Michaela $u Department of Neurology, University Hospital Basel, Basel, Switzerland $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Gaetano, Laura $u Department of Neurology, University Hospital Basel, Basel, Switzerland $u Medical Image Analysis Center (MIAC) AG, Basel, Switzerland $u Novartis Institutes for BioMedical Research Basel, Basel, Switzerland
- 700 1_
- $a Papadopoulou, Athina $u Department of Neurology, University Hospital Basel, Basel, Switzerland $u Department of Clinical Research, Faculty of Medicine, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Burguet Villena, Federico $u Department of Neurology, University Hospital Basel, Basel, Switzerland $u Department of Clinical Research, Faculty of Medicine, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Sprenger, Till $u Department of Neurology, University Hospital Basel, Basel, Switzerland $u University Hospital Zürich, Zurich, Switzerland
- 700 1_
- $a Radue, Ernst-Wilhelm $u Medical Image Analysis Center (MIAC) AG, Basel, Switzerland
- 700 1_
- $a Kappos, Ludwig $u Department of Neurology, University Hospital Basel, Basel, Switzerland $u Department of Clinical Research, Faculty of Medicine, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Bieri, Oliver $u Division of Radiological Physics, Department of Radiology, University Hospital Basel, Basel, Switzerland $u Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
- 700 1_
- $a Garcia, Meritxell $u Division of Neuroradiology, Department of Radiology, University Hospital Basel, Basel, Switzerland. meritxell.garciaalzamora@usz.ch $u Department of Neuroradiology, University Hospital Zürich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland. meritxell.garciaalzamora@usz.ch $1 https://orcid.org/0000000179464657
- 773 0_
- $w MED00009646 $t European radiology $x 1432-1084 $g Roč. 34, č. 3 (2024), s. 1680-1691
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37658894 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155638 $b ABA008
- 999 __
- $a ok $b bmc $g 2081168 $s 1216773
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 34 $c 3 $d 1680-1691 $e 20230902 $i 1432-1084 $m European radiology $n Eur Radiol $x MED00009646
- GRA __
- $a Swiss Multiple Sclerosis Society $p Swiss Multiple Sclerosis Society
- LZP __
- $a Pubmed-20240412